Prevalence of molecular markers of anti-malarial drug resistance in <it>Plasmodium vivax </it>and <it>Plasmodium falciparum </it>in two districts of Nepal

<p>Abstract</p> <p>Background</p> <p>Sulphadoxine-pyrimethamine (SP) and chloroquine (CQ) have been used in treatment of falciparum and vivax malaria in Nepal. Recently, resistance to both drugs have necessitated a change towards artemisinin combination therapy (ACT) ag...

Full description

Bibliographic Details
Main Authors: Bygbjerg Ib C, Kapel Christian MO, Adhikari Madhav, Thomsen Thomas, Schousboe Mette L, Ranjitkar Samir, Alifrangis Michael
Format: Article
Language:English
Published: BMC 2011-04-01
Series:Malaria Journal
Online Access:http://www.malariajournal.com/content/10/1/75